Uses of anti-CD40 antibodies

Details for Australian Patent Application No. 2008323815 (hide)

Owner Novartis AG Xoma Technology Ltd.

Inventors Kantak, Seema; Hsu, Ssucheng J.; Wang, Yongyu; Mirza, Amer M.; Luqman, Mohammad

Agent Fisher Adams Kelly

Pub. Number AU-A-2008323815

PCT Pub. Number WO2009/062054

Priority 61/002,545 09.11.07 US

Filing date 7 November 2008

Wipo publication date 14 May 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

27 May 2010 PCT application entered the National Phase

  PCT publication WO2009/062054 Priority application(s): WO2009/062054

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008323827-System and method of interfacing a surgical laser with an eye

2008323811-Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers